<code id='24611C1EF4'></code><style id='24611C1EF4'></style>
    • <acronym id='24611C1EF4'></acronym>
      <center id='24611C1EF4'><center id='24611C1EF4'><tfoot id='24611C1EF4'></tfoot></center><abbr id='24611C1EF4'><dir id='24611C1EF4'><tfoot id='24611C1EF4'></tfoot><noframes id='24611C1EF4'>

    • <optgroup id='24611C1EF4'><strike id='24611C1EF4'><sup id='24611C1EF4'></sup></strike><code id='24611C1EF4'></code></optgroup>
        1. <b id='24611C1EF4'><label id='24611C1EF4'><select id='24611C1EF4'><dt id='24611C1EF4'><span id='24611C1EF4'></span></dt></select></label></b><u id='24611C1EF4'></u>
          <i id='24611C1EF4'><strike id='24611C1EF4'><tt id='24611C1EF4'><pre id='24611C1EF4'></pre></tt></strike></i>

          hotspot

          hotspot

          author:focus    Page View:93
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          A Theranos scientist
          A Theranos scientist

          ErikaCheungandTylerShultzDanielBoczarski/GettyImagesforNewYorkMagazineShejoinedTheranosfreshoutofthe

          read more
          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more

          Maker of FluMist seeks to allow at

          ApatientreceivestheFluMistvaccineduringaclinicinSilverSpring,Md.TIMSLOAN/AFP/GettyImagesPeopleeligib